entertainment -WSS

entertainment

author：focus 2025-08-12 11:28:17 - browse：69419

Thomas Massie -- health policy coverage from STAT — Rep. Thomas Massie (R-Ky.) Kevin Dietsch/Getty Images

WASHINGTON — House lawmakers late Tuesday voted to attach a U.S. ban on controversial infectious disease research to legislation that could ultimately fund federal health agencies like the National Institutes of Health.

The bill would bar any federal agencies from funding so-called gain-of-function research, which involves altering a pathogen to study its spread, potentially making it more transmissible or severe in the process.

The spending bill already included a restriction on funding this research in any country determined to be a “foreign adversary,” including China. Scientists at the Wuhan Institute of Virology studied gain-of-function in some viruses, fueling theories that the Covid-19 pathogen was a lab leak. Those theories have never definitively been proven.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Impact of Dobbs ruling felt at reproductive medicine meeting

WSS

CEOs share strategies for surviving biotech slump

Hospital price transparency does save money, advocate argues

Medicare to cover more brain scans for Alzheimer’s patients

Solve the antibiotic resistance crisis with preventive drugs

Startup Neumora takes a novel depression drug to Phase 3

NIH confirmation hearing shows politicization of research

knowledge

entertainment

leisure time

Alkermes shareholders re

The explosion of genetic testing requires a new approach

Drug repurposing or repositioning? The language matters

Eli Lilly expects to double planned employment in Boston center

The cancer drug shortage isn’t new — and neither are the solutions

Solve the antibiotic resistance crisis with preventive drugs

Dobbs anniversary: the lost opportunity of abortion as health care

STAT Readout Newsletter: Today's biggest biotech updates

Sports medicine is finally prioritizing gender equality

Eli Lilly expects to double planned employment in Boston center

knowledge

STAT Summit: Michael J. Fox on progress in Parkinson's research

HHS leader on health, climate change and biopharma emissions

Beam Therapeutics to lay off 20% of its staff, re

Why health workers in Gaza are injured or die at high rates

How dance can help nurses traumatized by Covid

FDA gives detailed accounting of AI

entertainment

hotspot

entertainment

focus